dinutuximab beta

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

dinutuximab beta

Jul 24, 2024, 13:28 | Blog

Ruzanna Papyan: The significant role of anti-GD2 therapy in the treatment of relapsed or refractory neuroblastoma

Ruzanna Papyan shared a post on LinkedIn about a recent paper by Patricia Raiser et al., commenting:…

Jul 10, 2024, 05:18 | Insight

APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million

APEIRON Biologics AG (“APEIRON”), a leading Austrian biotech company, today announced that its shareholders have…

May 27, 2024, 12:01 | Drugs

Ruzanna Papyan: I suggest delving into the critical management of adverse events associated with dinutuximab beta

Ruzanna Papyan shared on LinkedIn: "Week 3 of the Global Access To Anti GD2 Campaign:…

All: 3 Posts: 1 - 100